These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 23680271)

  • 1. Serum magnesium and proton-pump inhibitors use: a cross-sectional study.
    Faulhaber GA; Ascoli BM; Lubini A; Mossmann M; Rossi G; Geib G; Furlanetto TW
    Rev Assoc Med Bras (1992); 2013; 59(3):276-9. PubMed ID: 23680271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?
    Luk CP; Parsons R; Lee YP; Hughes JD
    Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study.
    Nakashima A; Ohkido I; Yokoyama K; Mafune A; Urashima M; Yokoo T
    PLoS One; 2015; 10(11):e0143656. PubMed ID: 26618538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of proton pump inhibitors and hypomagnesemia in the community setting.
    Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D
    J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.
    Sharara AI; Chalhoub JM; Hammoud N; Harb AH; Sarkis FS; Hamadeh G
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):317-21. PubMed ID: 26499924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study.
    Bahtiri E; Islami H; Hoxha R; Gashi A; Thaçi K; Karakulak Ç; Thaçi S; Qorraj Bytyqi H
    Turk J Gastroenterol; 2017 Mar; 28(2):104-109. PubMed ID: 28082254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uses of proton pump inhibitors and hypomagnesemia.
    Gau JT; Yang YX; Chen R; Kao TC
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):553-9. PubMed ID: 22337212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
    Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
    Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study.
    Hess MW; de Baaij JH; Broekman MM; Bisseling TM; Haarhuis BJ; Tan AC; Te Morsche RH; Hoenderop JG; Bindels RJ; Drenth JP
    Pharmacogenet Genomics; 2017 Mar; 27(3):83-88. PubMed ID: 27926584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg.
    Furlanetto TW; Faulhaber GA
    Arch Intern Med; 2011 Aug; 171(15):1391-2. PubMed ID: 21555654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
    Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case series of proton pump inhibitor-induced hypomagnesemia.
    Hoorn EJ; van der Hoek J; de Man RA; Kuipers EJ; Bolwerk C; Zietse R
    Am J Kidney Dis; 2010 Jul; 56(1):112-6. PubMed ID: 20189276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.
    Hughes J; Y Y Chiu D; Kalra PA; Green D
    PLoS One; 2018; 13(5):e0197400. PubMed ID: 29799851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypomagnesemia and proton-pump inhibitors.
    Famularo G; Gasbarrone L; Minisola G
    Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomagnesemia Among Outpatient Long-Term Proton Pump Inhibitor Users.
    Biyik M; Solak Y; Ucar R; Cifci S; Tekis D; Polat İ; Göktepe MH; Sakiz D; Ataseven H; Demir A
    Am J Ther; 2017; 24(1):e52-e55. PubMed ID: 25353358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study.
    Misra PS; Alam A; Lipman ML; Nessim SJ
    BMC Nephrol; 2015 Aug; 16():136. PubMed ID: 26268579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetany, hypomagnesemia, and proton-pump inhibitors.
    Famularo G; Minisola G; Bravi MC; Colucci P; Gasbarrone L
    Am J Med; 2012 Oct; 125(10):e7-8. PubMed ID: 22800870
    [No Abstract]   [Full Text] [Related]  

  • 18. Magnesium Deficiency and Proton-Pump Inhibitor Use: A Clinical Review.
    William JH; Danziger J
    J Clin Pharmacol; 2016 Jun; 56(6):660-8. PubMed ID: 26582556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors and hypomagnesemia in patients with arrhythmias.
    Ragupathi L; Fonseka N; Sendecki JA; McCarey MM; Breecker SW; Whellan DJ
    Int J Clin Pract; 2015 Dec; 69(12):1525-6. PubMed ID: 26647010
    [No Abstract]   [Full Text] [Related]  

  • 20. Proton pump inhibitors and risk of hypomagnesemia.
    Pasina L; Zanotta D; Puricelli S; Djignefa DC; Bonoldi G
    Eur J Intern Med; 2015 Sep; 26(7):e25-6. PubMed ID: 26165831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.